Director Suvretta Capital Management, Llc bought $10,542,478 worth of shares (282,674 units at $37.30) (SEC Form 4)

2/9/26 6:28:51 PM ET

$MANE

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $MANE alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SUVRETTA CAPITAL MANAGEMENT, LLC

(Last)

(First)

(Middle)

540 MADISON AVENUE

7TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [ MANE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock, par value $0.00001 per share	02/04/2026		P		10,004⁽²⁾	A	$34.25⁽²⁾	3,525,462	I⁽¹⁾	See footnotes⁽¹⁾⁽²⁾
Common stock, par value $0.00001 per share	02/04/2026		P		10,676⁽³⁾	A	$34.74⁽³⁾	3,536,138	I⁽¹⁾	See footnotes⁽¹⁾⁽³⁾
Common stock, par value $0.00001 per share	02/04/2026		P		14,659⁽⁴⁾	A	$36.27⁽⁴⁾	3,550,797	I⁽¹⁾	See footnotes⁽¹⁾⁽⁴⁾
Common stock, par value $0.00001 per share	02/04/2026		P		53,344⁽⁵⁾	A	$37.11⁽⁵⁾	3,604,141	I⁽¹⁾	See footnotes⁽¹⁾⁽⁵⁾
Common stock, par value $0.00001 per share	02/04/2026		P		25,908⁽⁶⁾	A	$38.09⁽⁶⁾	3,630,049	I⁽¹⁾	See footnotes⁽¹⁾⁽⁶⁾
Common stock, par value $0.00001 per share	02/04/2026		P		18,489⁽⁷⁾	A	$38.9⁽⁷⁾	3,648,538	I⁽¹⁾	See footnotes⁽¹⁾⁽⁷⁾
Common stock, par value $0.00001 per share	02/04/2026		P		1,720⁽⁸⁾	A	$34.25⁽⁸⁾	372,579	I⁽¹⁾	See footnotes⁽¹⁾⁽⁸⁾
Common stock, par value $0.00001 per share	02/04/2026		P		1,835⁽⁹⁾	A	$34.74⁽⁹⁾	374,414	I⁽¹⁾	See footnotes⁽¹⁾⁽⁹⁾
Common stock, par value $0.00001 per share	02/04/2026		P		2,519⁽¹⁰⁾	A	$36.27⁽¹⁰⁾	376,933	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁰⁾
Common stock, par value $0.00001 per share	02/04/2026		P		9,168⁽¹¹⁾	A	$37.11⁽¹¹⁾	386,101	I⁽¹⁾	See footnotes⁽¹⁾⁽¹¹⁾
Common stock, par value $0.00001 per share	02/04/2026		P		4,453⁽¹²⁾	A	$38.09⁽¹²⁾	390,554	I⁽¹⁾	See footnotes⁽¹⁾⁽¹²⁾
Common stock, par value $0.00001 per share	02/04/2026		P		3,178⁽¹³⁾	A	$38.9⁽¹³⁾	393,732	I⁽¹⁾	See footnotes⁽¹⁾⁽¹³⁾
Common stock, par value $0.00001 per share	02/05/2026		P		3,832⁽¹⁴⁾	A	$36.07⁽¹⁴⁾	397,564	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁴⁾
Common stock, par value $0.00001 per share	02/05/2026		P		19,199⁽¹⁵⁾	A	$36.93⁽¹⁵⁾	416,763	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁵⁾
Common stock, par value $0.00001 per share	02/05/2026		P		38,771⁽¹⁶⁾	A	$37.63⁽¹⁶⁾	455,534	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁶⁾
Common stock, par value $0.00001 per share	02/05/2026		P		17,835⁽¹⁷⁾	A	$38.67⁽¹⁷⁾	473,369	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁷⁾
Common stock, par value $0.00001 per share	02/05/2026		P		16,563⁽¹⁸⁾	A	$39.8⁽¹⁸⁾	489,932	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁸⁾
Common stock, par value $0.00001 per share	02/06/2026		P		11,183⁽¹⁹⁾	A	$35.97⁽¹⁹⁾	501,115	I⁽¹⁾	See footnotes⁽¹⁾⁽¹⁹⁾
Common stock, par value $0.00001 per share	02/06/2026		P		19,338⁽²⁰⁾	A	$36.55⁽²⁰⁾	520,453	I⁽¹⁾	See footnotes⁽¹⁾⁽²⁰⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

SUVRETTA CAPITAL MANAGEMENT, LLC

(Last)

(First)

(Middle)

540 MADISON AVENUE

7TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Cowen Aaron

(Last)

(First)

(Middle)

C/O SUVRETTA CAPITAL MANAGEMENT, LLC

540 MADISON AVENUE, 7TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Averill Master Fund, Ltd.

(Last)

(First)

(Middle)

C/O SUVRETTA CAPITAL MANAGEMENT, LLC

540 MADISON AVENUE, 7TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Averill Madison Master Fund, Ltd.

(Last)

(First)

(Middle)

C/O SUVRETTA CAPITAL MANAGEMENT, LLC

540 MADISON AVENUE, 7TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Notes are included on Exhibit 99.1.

2. Notes are included on Exhibit 99.1.

3. Notes are included on Exhibit 99.1.

4. Notes are included on Exhibit 99.1.

5. Notes are included on Exhibit 99.1.

6. Notes are included on Exhibit 99.1.

7. Notes are included on Exhibit 99.1.

8. Notes are included on Exhibit 99.1.

9. Notes are included on Exhibit 99.1.

10. Notes are included on Exhibit 99.1.

11. Notes are included on Exhibit 99.1.

12. Notes are included on Exhibit 99.1.

13. Notes are included on Exhibit 99.1.

14. Notes are included on Exhibit 99.1.

15. Notes are included on Exhibit 99.1.

16. Notes are included on Exhibit 99.1.

17. Notes are included on Exhibit 99.1.

18. Notes are included on Exhibit 99.1.

19. Notes are included on Exhibit 99.1.

20. Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature

	Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $MANE alert in real time by email

Date

Price Target

Rating

Analyst

3/2/2026

Overweight

Cantor Fitzgerald

3/2/2026

$85.00

Buy

Citigroup

3/2/2026

$75.00

Buy

Jefferies

3/2/2026

$75.00

Outperform

Leerink Partners

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction Date (Month/Day/Year)

2A. Deemed Execution Date, if any (Month/Day/Year)

3. Transaction Code (Instr. 8)

4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)

6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

7. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

Amount

(A) or (D)

Price

Common stock, par value $0.00001 per share

02/04/2026

10,004⁽²⁾

$34.25⁽²⁾

3,525,462

I⁽¹⁾

See footnotes⁽¹⁾⁽²⁾

Common stock, par value $0.00001 per share

02/04/2026

10,676⁽³⁾

$34.74⁽³⁾

3,536,138

I⁽¹⁾

See footnotes⁽¹⁾⁽³⁾

Common stock, par value $0.00001 per share

02/04/2026

14,659⁽⁴⁾

$36.27⁽⁴⁾

3,550,797

I⁽¹⁾

See footnotes⁽¹⁾⁽⁴⁾

Common stock, par value $0.00001 per share

02/04/2026

53,344⁽⁵⁾

$37.11⁽⁵⁾

3,604,141

I⁽¹⁾

See footnotes⁽¹⁾⁽⁵⁾

Common stock, par value $0.00001 per share

02/04/2026

25,908⁽⁶⁾

$38.09⁽⁶⁾

3,630,049

I⁽¹⁾

See footnotes⁽¹⁾⁽⁶⁾

Common stock, par value $0.00001 per share

02/04/2026

18,489⁽⁷⁾

$38.9⁽⁷⁾

3,648,538

I⁽¹⁾

See footnotes⁽¹⁾⁽⁷⁾

Common stock, par value $0.00001 per share

02/04/2026

1,720⁽⁸⁾

$34.25⁽⁸⁾

372,579

I⁽¹⁾

See footnotes⁽¹⁾⁽⁸⁾

Common stock, par value $0.00001 per share

02/04/2026

1,835⁽⁹⁾

$34.74⁽⁹⁾

374,414

I⁽¹⁾

See footnotes⁽¹⁾⁽⁹⁾

Common stock, par value $0.00001 per share

02/04/2026

2,519⁽¹⁰⁾

$36.27⁽¹⁰⁾

376,933

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁰⁾

Common stock, par value $0.00001 per share

02/04/2026

9,168⁽¹¹⁾

$37.11⁽¹¹⁾

386,101

I⁽¹⁾

See footnotes⁽¹⁾⁽¹¹⁾

Common stock, par value $0.00001 per share

02/04/2026

4,453⁽¹²⁾

$38.09⁽¹²⁾

390,554

I⁽¹⁾

See footnotes⁽¹⁾⁽¹²⁾

Common stock, par value $0.00001 per share

02/04/2026

3,178⁽¹³⁾

$38.9⁽¹³⁾

393,732

I⁽¹⁾

See footnotes⁽¹⁾⁽¹³⁾

Common stock, par value $0.00001 per share

02/05/2026

3,832⁽¹⁴⁾

$36.07⁽¹⁴⁾

397,564

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁴⁾

Common stock, par value $0.00001 per share

02/05/2026

19,199⁽¹⁵⁾

$36.93⁽¹⁵⁾

416,763

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁵⁾

Common stock, par value $0.00001 per share

02/05/2026

38,771⁽¹⁶⁾

$37.63⁽¹⁶⁾

455,534

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁶⁾

Common stock, par value $0.00001 per share

02/05/2026

17,835⁽¹⁷⁾

$38.67⁽¹⁷⁾

473,369

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁷⁾

Common stock, par value $0.00001 per share

02/05/2026

16,563⁽¹⁸⁾

$39.8⁽¹⁸⁾

489,932

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁸⁾

Common stock, par value $0.00001 per share

02/06/2026

11,183⁽¹⁹⁾

$35.97⁽¹⁹⁾

501,115

I⁽¹⁾

See footnotes⁽¹⁾⁽¹⁹⁾

Common stock, par value $0.00001 per share

02/06/2026

19,338⁽²⁰⁾

$36.55⁽²⁰⁾

520,453

I⁽¹⁾

See footnotes⁽¹⁾⁽²⁰⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Date

Price Target

Rating

Analyst

3/2/2026

Overweight

Cantor Fitzgerald

3/2/2026

$85.00

Buy

Citigroup

3/2/2026

$75.00

Buy

Jefferies

3/2/2026

$75.00

Outperform

Leerink Partners

Director Suvretta Capital Management, Llc bought $10,542,478 worth of shares (282,674 units at $37.30) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MANE

Director Suvretta Capital Management, Llc bought $10,542,478 worth of shares (282,674 units at $37.30) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$MANE

$MANE
SEC Filings

SEC Form 10-K filed by Veradermics Incorporated

Veradermics Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form SCHEDULE 13G filed by Veradermics Incorporated

$MANE
Press Releases

Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Veradermics to Participate in Upcoming March Investor Conferences

$MANE
Insider Trading

Amendment: Director Childs John W bought $4,999,989 worth of shares (294,117 units at $17.00) (SEC Form 4)